reported that SETD7 overexpression can promote HepG2 cell proliferation, whereas SETD7 knockdown can inhibit SMMC‐7721 cell proliferation by regulating the cell cycle, indicating that SETD7 plays a critical role in HCC [32]. Here, SETD7 is linked to hepatocellular carcinoma.